CSIMarket
 

Apollo Endosurgery inc   (NASDAQ: APEN)

Apollo Endosurgery Inc 's

Competitiveness




 

APEN Sales vs. its Competitors Q4 2022



Comparing the current results to its competitors, Apollo Endosurgery Inc reported Revenue increase in the 4 quarter 2022 by 31.8 % year on year.
The sales growth was above Apollo Endosurgery Inc 's competitors' average revenue growth of 26.46 %, achieved in the same quarter.

List of APEN Competitors





Revenue Growth Comparisons




Net Income Comparison


Apollo Endosurgery inc recorded a net loss, as well as most of its competitors.

<<  APEN Stock Performance Comparisons



  

Overall company Market Share Q4 2022

Due to strong revenue growth of 31.8 % in Overall company company increased its market share in this division.


<<  More on APEN Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Apollo Endosurgery inc




Reshape Lifesciences Inc
Share Performance



-96.56%
This Year



Reshape Lifesciences Inc
Profile

Reshape Lifesciences Inc's business model revolves around developing and commercializing innovative medical devices to treat obesity and metabolic diseases.

More about Reshape Lifesciences Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 26.226 mill. $ 2.421 mill. $ -10.184 mill.

Sources: Apollo Endosurgery inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Apollo Endosurgery inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.